Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1990-4-5
|
pubmed:abstractText |
Since several aldosterone metabolites are known to be active, we have assessed the mineralocorticoid biological and renal receptor binding activities of the aldosterone metabolites, 21-deoxyaldosterone (21-deoxy-Aldo), 21-deoxytetrahydroaldosterone (21-deoxy-THAldo), and 3 alpha, 5 beta-tetrahydroaldosterone (THAldo). We synthesized these steroids by bioreduction of aldosterone with intestinal bacteria. Mineralocorticoid agonist activity of 21-deoxy-Aldo, 21-deoxy-THAldo and THAldo, determined by bioassay using adrenalectomized rats, was 1-5%, less than 0.01%, and 0.1-0.5% that of aldosterone, respectively. 21-Deoxy-Aldo showed no antagonist activity. The relative affinity in competing with [3H]aldosterone for binding to mineralocorticoid receptors in adrenalectomized rat kidney cytosols was 94%, less than 0.01%, and less than 0.01% that of aldosterone. The relative binding affinity for rat renal glucocorticoid receptors was 23%, less than 0.01%, and less than 0.01% that of dexamethasone, and for corticosteroid-binding globulin 17%, less than 0.01%, and less than 0.01% that of cortisol. These results show that the naturally occurring steroid, 21-deoxy-Aldo, possesses mineralocorticoid agonist activity which is equivalent to that of 11-deoxycorticosterone, and has substantial affinity for rat renal mineralocorticoid and glucocorticoid receptors. The results also implicate the pathophysiological role of 21-deoxy-Aldo as a potential mineralocorticoid in 21-hydroxylase deficiency, where urinary excretion of this steroid is invariably elevated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/21-deoxyaldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Mineralocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Glucocorticoid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Mineralocorticoid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Steroid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1410-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2155101-Adrenalectomy,
pubmed-meshheading:2155101-Aldosterone,
pubmed-meshheading:2155101-Animals,
pubmed-meshheading:2155101-Binding, Competitive,
pubmed-meshheading:2155101-Cytosol,
pubmed-meshheading:2155101-Dexamethasone,
pubmed-meshheading:2155101-Kidney,
pubmed-meshheading:2155101-Male,
pubmed-meshheading:2155101-Mineralocorticoids,
pubmed-meshheading:2155101-Rats,
pubmed-meshheading:2155101-Rats, Inbred Strains,
pubmed-meshheading:2155101-Receptors, Glucocorticoid,
pubmed-meshheading:2155101-Receptors, Mineralocorticoid,
pubmed-meshheading:2155101-Receptors, Steroid
|
pubmed:year |
1990
|
pubmed:articleTitle |
Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
|
pubmed:affiliation |
Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|